Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70 Sell
4
-4
-50% -$85 ﹤0.01% 593
2026
Q1
$153 Sell
8
-3
-27% -$67 ﹤0.01% 581
2025
Q4
$217 Hold
11
﹤0.01% 579
2025
Q3
$273 Hold
11
﹤0.01% 548
2025
Q2
$220 Hold
11
﹤0.01% 494
2025
Q1
$146 Hold
11
﹤0.01% 433
2024
Q4
$195 Hold
11
﹤0.01% 437
2024
Q3
$256 Hold
11
﹤0.01% 436
2024
Q2
$280 Hold
11
﹤0.01% 423
2024
Q1
$372 Hold
11
﹤0.01% 440
2023
Q4
$411 Hold
11
﹤0.01% 437
2023
Q3
$415 Hold
11
﹤0.01% 442
2023
Q2
$433 Hold
11
﹤0.01% 459
2023
Q1
$463 Hold
11
﹤0.01% 370
2022
Q4
$392 Hold
11
﹤0.01% 361
2022
Q3
$314 Hold
11
﹤0.01% 352
2022
Q2
$335 Hold
11
﹤0.01% 345
2022
Q1
$461 Hold
11
﹤0.01% 337
2021
Q4
$541 Buy
+11
New +$493 ﹤0.01% 333

Other funds holding ADNT

PFS Partners's ADNT Position: Q2 2026 in Review

PFS Partners reduced its Adient (ADNT) stake by 50% in Q2 2026, selling an estimated $85 and leaving 4 shares worth $70. The position accounts for ﹤0.01% of the portfolio, ranked #593.

PFS Partners first reported a position in ADNT in Q4 2021 and has held it in 19 quarters since. The position peaked at $541 in Q4 2021. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • PFS Partners held 4 shares of Adient worth $70 as of Q2 2026.
  • PFS Partners sold 4 Adient shares in Q2 2026, an estimated $85.
  • Adient made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #593 holding.
  • PFS Partners first reported a position in Adient in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's Adient position peaked at $541 in Q4 2021.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.